Press Releases :: Hancock Jaffe Laboratories, Inc. (HJLI)

Hancock Jaffe Enrolls Four Additional Patients for First-in-Human VenoValve Study

Mar 21, 2019

Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute

Mar 18, 2019

Hancock Jaffe Completes $2.7 Million Private Placement of Common Stock

Mar 13, 2019

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

Feb 19, 2019

Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study

Jan 28, 2019

Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

Jan 15, 2019

Hancock Jaffe Announces End Points for First-in-Human VenoValve Study

Jan 9, 2019

Hancock Jaffe Receives Approval for First-in-Human VenoValve Study

Dec 17, 2018

Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute

Dec 4, 2018

Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia

Nov 20, 2018

Show / Refresh / Reset / Delete

Views until show: 5
Seconds until show: 5